
2023-2029 Global Outsourcing Drug Discovery Industry Research & Trends Analysis Report
Discover the latest insights into the booming Outsourcing Drug Discovery Market. This report analyzes market size, growth trends (CAGR ), key players, and regional performance, offering valuable data for investors and industry professionals. Explore market drivers, restraints, and future projections for -.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
According to the latest research analysis,the global market for Outsourcing Drug Discovery should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China Outsourcing Drug Discovery market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Outsourcing Drug Discovery market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, Chemistry Services segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, OTC has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Outsourcing Drug Discovery include Albany Molecular Research, Inc., Evotec AG, Asclepia MedChem Solutions, Aurelia Bioscience Ltd, Axxam SpA, BioDuro, Charles River Laboratories, Inc., Charnwood Molecular and CreaGen Biosciences, Inc., etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive study of the global market for Outsourcing Drug Discovery.
Data-Driven Insights: Highlights from Our Report
(1) Global Outsourcing Drug Discovery market size (value), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Outsourcing Drug Discovery market competitive situation, revenue and market share, from 2018 to 2022.
(3) China Outsourcing Drug Discovery market competitive situation, revenue and market share, from 2018 to 2022.
(4) Global Outsourcing Drug Discovery segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Outsourcing Drug Discovery segment by type and by application and regional segment by type and by application.
(6) Outsourcing Drug Discovery industry supply chain, upstream, midstream and downstream analysis.
Breaking Down Market Segments by Region: A Deep Dive Analysis
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Understanding Market Segments by Type: A Comparative Analysis
Chemistry Services
Biology Services
High Throughput Screening Services
Lead Optimization Services
Market Segmentation by Application: Dividing Key Markets and Identifying Opportunities
OTC
Rx
Understanding Market Segments by Key Players: Insights and Opportunities
Albany Molecular Research, Inc.
Evotec AG
Asclepia MedChem Solutions
Aurelia Bioscience Ltd
Axxam SpA
BioDuro
Charles River Laboratories, Inc.
Charnwood Molecular
CreaGen Biosciences, Inc.
Crown Bioscience
Cyprotex PLC, an Evotec AG Company
Domainex
Nanosyn, Inc.
Olon Ricerca Biosciences
Pharmaron, Inc.
TCG Lifesciences Pvt Ltd.
Viva Biotech, Ltd.
WuXi AppTec Co. Ltd.
1 Market Overview
1.1 Product Overview and Scope of Outsourcing Drug Discovery
1.2 Global Outsourcing Drug Discovery Market Size and Forecast
1.3 China Outsourcing Drug Discovery Market Size and Forecast
1.4 China Market Percentage in Global
1.4.1 By Revenue, China Outsourcing Drug Discovery Share in Global Market, 2018-2029
1.4.2 Outsourcing Drug Discovery Market Size: China VS Global, 2018-2029
1.5 Outsourcing Drug Discovery Market Dynamics
1.5.1 Outsourcing Drug Discovery Market Drivers
1.5.2 Outsourcing Drug Discovery Market Restraints
1.5.3 Outsourcing Drug Discovery Industry Trends
1.5.4 Outsourcing Drug Discovery Industry Policy
2 Global Competitive Situation by Company
2.1 Global Outsourcing Drug Discovery Revenue by Company (2018-2023)
2.2 Global Outsourcing Drug Discovery Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.3 Global Outsourcing Drug Discovery Concentration Ratio
2.4 Global Outsourcing Drug Discovery Mergers & Acquisitions, Expansion Plans
2.5 Global Outsourcing Drug Discovery Manufacturers Product Type
3 China Competitive Situation by Company
3.1 China Outsourcing Drug Discovery Revenue by Company (2018-2023)
3.2 China Outsourcing Drug Discovery Outsourcing Drug Discovery Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.3 China Outsourcing Drug Discovery, Revenue Percentage of Local Players VS Foreign Manufacturers (2018-2023)
4 Industry Chain Analysis
4.1 Outsourcing Drug Discovery Industry Chain
4.2 Outsourcing Drug Discovery Upstream Analysis
4.3 Outsourcing Drug Discovery Midstream Analysis
4.4 Outsourcing Drug Discovery Downstream Analysis
5 Sights by Type
5.1 Outsourcing Drug Discovery Classification
5.1.1 Chemistry Services
5.1.2 Biology Services
5.1.3 High Throughput Screening Services
5.1.4 Lead Optimization Services
5.2 By Type, Global Outsourcing Drug Discovery Market Size & CAGR, 2018 VS 2022 VS 2029
5.3 By Type, Global Outsourcing Drug Discovery Revenue, 2018-2029
6 Sights by Application
6.1 Outsourcing Drug Discovery Segment by Application
6.1.1 OTC
6.1.2 Rx
6.2 By Application, Global Outsourcing Drug Discovery Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Application, Global Outsourcing Drug Discovery Revenue, 2018-2029
7 Sales Sights by Region
7.1 By Region, Global Outsourcing Drug Discovery Market Size, 2018 VS 2022 VS 2029
7.2 By Region, Global Outsourcing Drug Discovery Market Size, 2018-2029
7.3 North America
7.3.1 North America Outsourcing Drug Discovery Market Size & Forecasts, 2018-2029
7.3.2 By Country, North America Outsourcing Drug Discovery Market Size Market Share
7.4 Europe
7.4.1 Europe Outsourcing Drug Discovery Market Size & Forecasts, 2018-2029
7.4.2 By Country, Europe Outsourcing Drug Discovery Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Outsourcing Drug Discovery Market Size & Forecasts, 2018-2029
7.5.2 By Country/Region, Asia Pacific Outsourcing Drug Discovery Market Size Market Share
7.6 South America
7.6.1 South America Outsourcing Drug Discovery Market Size & Forecasts, 2018-2029
7.6.2 By Country, South America Outsourcing Drug Discovery Market Size Market Share
7.7 Middle East & Africa
8 Sights by Country Level
8.1 By Country, Global Outsourcing Drug Discovery Market Size & CAGR,2018 VS 2022 VS 2029
8.2 By Country, Global Outsourcing Drug Discovery Market Size, 2018-2029
8.3 U.S.
8.3.1 U.S. Outsourcing Drug Discovery Market Size, 2018-2029
8.3.2 By Company, U.S. Outsourcing Drug Discovery Revenue Market Share, 2018-2023
8.3.3 By Type, U.S. Outsourcing Drug Discovery Revenue Market Share, 2022 VS 2029
8.3.4 By Application, U.S. Outsourcing Drug Discovery Revenue Market Share, 2022 VS 2029
8.4 Europe
8.4.1 Europe Outsourcing Drug Discovery Market Size, 2018-2029
8.4.2 By Company, Europe Outsourcing Drug Discovery Revenue Market Share, 2018-2023
8.4.3 By Type, Europe Outsourcing Drug Discovery Revenue Market Share, 2022 VS 2029
8.4.4 By Application, Europe Outsourcing Drug Discovery Revenue Market Share, 2022 VS 2029
8.5 China
8.5.1 China Outsourcing Drug Discovery Market Size, 2018-2029
8.5.2 By Company, China Outsourcing Drug Discovery Revenue Market Share, 2018-2023
8.5.3 By Type, China Outsourcing Drug Discovery Revenue Market Share, 2022 VS 2029
8.5.4 By Application, China Outsourcing Drug Discovery Revenue Market Share, 2022 VS 2029
8.6 Japan
8.6.1 Japan Outsourcing Drug Discovery Market Size, 2018-2029
8.6.2 By Company, Japan Outsourcing Drug Discovery Revenue Market Share, 2018-2023
8.6.3 By Type, Japan Outsourcing Drug Discovery Revenue Market Share, 2022 VS 2029
8.6.4 By Application, Japan Outsourcing Drug Discovery Revenue Market Share, 2022 VS 2029
8.7 South Korea
8.7.1 South Korea Outsourcing Drug Discovery Market Size, 2018-2029
8.7.2 By Company, South Korea Outsourcing Drug Discovery Revenue Market Share, 2018-2023
8.7.3 By Type, South Korea Outsourcing Drug Discovery Revenue Market Share, 2022 VS 2029
8.7.4 By Application, South Korea Outsourcing Drug Discovery Revenue Market Share, 2022 VS 2029
8.8 Southeast Asia
8.8.1 Southeast Asia Outsourcing Drug Discovery Market Size, 2018-2029
8.8.2 By Company, Southeast Asia Outsourcing Drug Discovery Revenue Market Share, 2018-2023
8.8.3 By Type, Southeast Asia Outsourcing Drug Discovery Revenue Market Share, 2022 VS 2029
8.8.4 By Application, Southeast Asia Outsourcing Drug Discovery Revenue Market Share, 2022 VS 2029
8.9 India
8.9.1 India Outsourcing Drug Discovery Market Size, 2018-2029
8.9.2 By Company, India Outsourcing Drug Discovery Revenue Market Share, 2018-2023
8.9.3 By Type, India Outsourcing Drug Discovery Revenue Market Share, 2022 VS 2029
8.9.4 By Application, India Outsourcing Drug Discovery Revenue Market Share, 2022 VS 2029
8.10 Middle East & Asia
8.10.1 Middle East & Asia Outsourcing Drug Discovery Market Size, 2018-2029
8.10.2 By Company, Middle East & Asia Outsourcing Drug Discovery Revenue Market Share, 2018-2023
8.10.3 By Type, Middle East & Asia Outsourcing Drug Discovery Revenue Market Share, 2022 VS 2029
8.10.4 By Application, Middle East & Asia Outsourcing Drug Discovery Revenue Market Share, 2022 VS 2029
9 Global Manufacturers Profile
9.1 Albany Molecular Research, Inc.
9.1.1 Albany Molecular Research, Inc. Company Information, Head Office, Market Area and Industry Position
9.1.2 Albany Molecular Research, Inc. Company Profile and Main Business
9.1.3 Albany Molecular Research, Inc. Outsourcing Drug Discovery Models, Specifications and Application
9.1.4 Albany Molecular Research, Inc. Outsourcing Drug Discovery Revenue and Gross Margin, 2018-2023
9.1.5 Albany Molecular Research, Inc. Recent Developments
9.2 Evotec AG
9.2.1 Evotec AG Company Information, Head Office, Market Area and Industry Position
9.2.2 Evotec AG Company Profile and Main Business
9.2.3 Evotec AG Outsourcing Drug Discovery Models, Specifications and Application
9.2.4 Evotec AG Outsourcing Drug Discovery Revenue and Gross Margin, 2018-2023
9.2.5 Evotec AG Recent Developments
9.3 Asclepia MedChem Solutions
9.3.1 Asclepia MedChem Solutions Company Information, Head Office, Market Area and Industry Position
9.3.2 Asclepia MedChem Solutions Company Profile and Main Business
9.3.3 Asclepia MedChem Solutions Outsourcing Drug Discovery Models, Specifications and Application
9.3.4 Asclepia MedChem Solutions Outsourcing Drug Discovery Revenue and Gross Margin, 2018-2023
9.3.5 Asclepia MedChem Solutions Recent Developments
9.4 Aurelia Bioscience Ltd
9.4.1 Aurelia Bioscience Ltd Company Information, Head Office, Market Area and Industry Position
9.4.2 Aurelia Bioscience Ltd Company Profile and Main Business
9.4.3 Aurelia Bioscience Ltd Outsourcing Drug Discovery Models, Specifications and Application
9.4.4 Aurelia Bioscience Ltd Outsourcing Drug Discovery Revenue and Gross Margin, 2018-2023
9.4.5 Aurelia Bioscience Ltd Recent Developments
9.5 Axxam SpA
9.5.1 Axxam SpA Company Information, Head Office, Market Area and Industry Position
9.5.2 Axxam SpA Company Profile and Main Business
9.5.3 Axxam SpA Outsourcing Drug Discovery Models, Specifications and Application
9.5.4 Axxam SpA Outsourcing Drug Discovery Revenue and Gross Margin, 2018-2023
9.5.5 Axxam SpA Recent Developments
9.6 BioDuro
9.6.1 BioDuro Company Information, Head Office, Market Area and Industry Position
9.6.2 BioDuro Company Profile and Main Business
9.6.3 BioDuro Outsourcing Drug Discovery Models, Specifications and Application
9.6.4 BioDuro Outsourcing Drug Discovery Revenue and Gross Margin, 2018-2023
9.6.5 BioDuro Recent Developments
9.7 Charles River Laboratories, Inc.
9.7.1 Charles River Laboratories, Inc. Company Information, Head Office, Market Area and Industry Position
9.7.2 Charles River Laboratories, Inc. Company Profile and Main Business
9.7.3 Charles River Laboratories, Inc. Outsourcing Drug Discovery Models, Specifications and Application
9.7.4 Charles River Laboratories, Inc. Outsourcing Drug Discovery Revenue and Gross Margin, 2018-2023
9.7.5 Charles River Laboratories, Inc. Recent Developments
9.8 Charnwood Molecular
9.8.1 Charnwood Molecular Company Information, Head Office, Market Area and Industry Position
9.8.2 Charnwood Molecular Company Profile and Main Business
9.8.3 Charnwood Molecular Outsourcing Drug Discovery Models, Specifications and Application
9.8.4 Charnwood Molecular Outsourcing Drug Discovery Revenue and Gross Margin, 2018-2023
9.8.5 Charnwood Molecular Recent Developments
9.9 CreaGen Biosciences, Inc.
9.9.1 CreaGen Biosciences, Inc. Company Information, Head Office, Market Area and Industry Position
9.9.2 CreaGen Biosciences, Inc. Company Profile and Main Business
9.9.3 CreaGen Biosciences, Inc. Outsourcing Drug Discovery Models, Specifications and Application
9.9.4 CreaGen Biosciences, Inc. Outsourcing Drug Discovery Revenue and Gross Margin, 2018-2023
9.9.5 CreaGen Biosciences, Inc. Recent Developments
9.10 Crown Bioscience
9.10.1 Crown Bioscience Company Information, Head Office, Market Area and Industry Position
9.10.2 Crown Bioscience Company Profile and Main Business
9.10.3 Crown Bioscience Outsourcing Drug Discovery Models, Specifications and Application
9.10.4 Crown Bioscience Outsourcing Drug Discovery Revenue and Gross Margin, 2018-2023
9.10.5 Crown Bioscience Recent Developments
9.11 Cyprotex PLC, an Evotec AG Company
9.11.1 Cyprotex PLC, an Evotec AG Company Company Information, Head Office, Market Area and Industry Position
9.11.2 Cyprotex PLC, an Evotec AG Company Company Profile and Main Business
9.11.3 Cyprotex PLC, an Evotec AG Company Outsourcing Drug Discovery Models, Specifications and Application
9.11.4 Cyprotex PLC, an Evotec AG Company Outsourcing Drug Discovery Revenue and Gross Margin, 2018-2023
9.11.5 Cyprotex PLC, an Evotec AG Company Recent Developments
9.12 Domainex
9.12.1 Domainex Company Information, Head Office, Market Area and Industry Position
9.12.2 Domainex Company Profile and Main Business
9.12.3 Domainex Outsourcing Drug Discovery Models, Specifications and Application
9.12.4 Domainex Outsourcing Drug Discovery Revenue and Gross Margin, 2018-2023
9.12.5 Domainex Recent Developments
9.13 Nanosyn, Inc.
9.13.1 Nanosyn, Inc. Company Information, Head Office, Market Area and Industry Position
9.13.2 Nanosyn, Inc. Company Profile and Main Business
9.13.3 Nanosyn, Inc. Outsourcing Drug Discovery Models, Specifications and Application
9.13.4 Nanosyn, Inc. Outsourcing Drug Discovery Revenue and Gross Margin, 2018-2023
9.13.5 Nanosyn, Inc. Recent Developments
9.14 Olon Ricerca Biosciences
9.14.1 Olon Ricerca Biosciences Company Information, Head Office, Market Area and Industry Position
9.14.2 Olon Ricerca Biosciences Company Profile and Main Business
9.14.3 Olon Ricerca Biosciences Outsourcing Drug Discovery Models, Specifications and Application
9.14.4 Olon Ricerca Biosciences Outsourcing Drug Discovery Revenue and Gross Margin, 2018-2023
9.14.5 Olon Ricerca Biosciences Recent Developments
9.15 Pharmaron, Inc.
9.15.1 Pharmaron, Inc. Company Information, Head Office, Market Area and Industry Position
9.15.2 Pharmaron, Inc. Company Profile and Main Business
9.15.3 Pharmaron, Inc. Outsourcing Drug Discovery Models, Specifications and Application
9.15.4 Pharmaron, Inc. Outsourcing Drug Discovery Revenue and Gross Margin, 2018-2023
9.15.5 Pharmaron, Inc. Recent Developments
9.16 TCG Lifesciences Pvt Ltd.
9.16.1 TCG Lifesciences Pvt Ltd. Company Information, Head Office, Market Area and Industry Position
9.16.2 TCG Lifesciences Pvt Ltd. Company Profile and Main Business
9.16.3 TCG Lifesciences Pvt Ltd. Outsourcing Drug Discovery Models, Specifications and Application
9.16.4 TCG Lifesciences Pvt Ltd. Outsourcing Drug Discovery Revenue and Gross Margin, 2018-2023
9.16.5 TCG Lifesciences Pvt Ltd. Recent Developments
9.17 Viva Biotech, Ltd.
9.17.1 Viva Biotech, Ltd. Company Information, Head Office, Market Area and Industry Position
9.17.2 Viva Biotech, Ltd. Company Profile and Main Business
9.17.3 Viva Biotech, Ltd. Outsourcing Drug Discovery Models, Specifications and Application
9.17.4 Viva Biotech, Ltd. Outsourcing Drug Discovery Revenue and Gross Margin, 2018-2023
9.17.5 Viva Biotech, Ltd. Recent Developments
9.18 WuXi AppTec Co. Ltd.
9.18.1 WuXi AppTec Co. Ltd. Company Information, Head Office, Market Area and Industry Position
9.18.2 WuXi AppTec Co. Ltd. Company Profile and Main Business
9.18.3 WuXi AppTec Co. Ltd. Outsourcing Drug Discovery Models, Specifications and Application
9.18.4 WuXi AppTec Co. Ltd. Outsourcing Drug Discovery Revenue and Gross Margin, 2018-2023
9.18.5 WuXi AppTec Co. Ltd. Recent Developments
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer
Research Methodology:
Outsourcing Drug Discovery Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|